Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals' board met on August 30, 2025 and approved several routine items. It appointed CS Rupal Patel as the new Secretarial Auditor for a five-year term starting FY 2025-26. It also appointed M/s. Shah Sanghvi and Associates as the new Statutory Auditors for five consecutive years, replacing the retiring auditors under the normal rotation mandated by Section 139(2) of the Companies Act, 2013, subject to shareholder approval. The board approved the Director's Report and Secretarial Audit Report for the year ended March 31, 2025, and fixed the 32nd AGM for September 29, 2025 at 11:30 am via video conferencing. The Register of Members will be closed from September 23 to September 29, 2025 for AGM purposes.
This is standard corporate housekeeping ahead of the AGM. The auditor change is a mandatory rotation, not a midterm resignation, so there are no negative governance signals. Expect neutral impact on the stock.